Tharimmune, Inc. Files 8-K on Director Changes
Ticker: CNTN · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation
TL;DR
Board shakeup at Tharimmune, Inc. - new directors elected, compensation likely changing.
AI Summary
On February 21, 2025, Tharimmune, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates the election of new directors and potential adjustments to officer compensation, though specific dollar amounts and names of newly appointed individuals are not detailed in this excerpt.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect the company's future direction and stability.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- February 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1200 Route 22 East, Suite 2000 (address) — Principal executive office address
- Bridgewater, NJ 08807 (address) — Principal executive office address
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but the specific names and number of newly elected directors are not detailed in this excerpt.
What are the details of the compensatory arrangements for certain officers?
The filing mentions compensatory arrangements for certain officers, but specific details regarding these arrangements are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 21, 2025.
What is Tharimmune, Inc.'s state of incorporation?
Tharimmune, Inc. is incorporated in Delaware.
What is the principal executive office address of Tharimmune, Inc.?
The principal executive office address of Tharimmune, Inc. is 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Tharimmune, Inc. (CNTN).